Navigation Links
BioLineRx Reports Third Quarter 2013 Financial Results
Date:11/13/2013

JERUSALEM, Nov. 13, 2013 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX; TASE: BLRX), a biopharmaceutical development company, today reported its results for the third quarter ending September 30, 2013.

(Logo: http://photos.prnewswire.com/prnh/20130730/630769)

Kinneret Savitsky, Ph.D., Chief Executive Officer of BioLineRx, stated, "As we approach the end of 2013, we see the Company's continued progress towards several significant catalysts over the next several quarters. For instance, one of our most advanced assets, BL-1040 for the prevention of ventricular remodeling post AMI, is progressing as scheduled at full steam in the PRESERVATION I CE-Mark registration trial. Fifty-five sites are currently open, including 14 in the U.S., and final results are expected in 2014."

Other highlights

BL-8040 (AML and other hematological indications):

  • Granted orphan drug designation by the FDA, allowing a faster clinical path toward commercialization 
  • Added Memorial Sloan Kettering Cancer Center in New York to join the Phase 2 multi-center study, bringing the total number of sites to eight
  • Received patent allowance through 2029 from the USPTO for method of obtaining stem cells
  • "During the third quarter, we made significant progress in our Phase 2 clinical trial for BL-8040, a best-in-class CXCR4 antagonist for the treatment of hematological cancers such as AML. In September, we received orphan drug status from the FDA, a designation with significant positive implications for BL-8040 as it advances through the clinic, including a seven-year market exclusivity period, clinical protocol assistance with the FDA, and federal grants and tax credits. We remain on track to deliver partial results from the trial by the end of this year, with final results expected in the se
    '/>"/>

    SOURCE BioLineRx Ltd.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12

    Related medicine technology :

    1. BioLineRx to Report Third Quarter 2013 Results on November 13, 2013
    2. BioLineRx to Hold Analyst and Investor Day in New York on November 21, 2013
    3. BioLineRx Receives Regulatory Approval to Commence Phase 1/2 Trial for Novel Treatment of Celiac Disease
    4. BioLineRx Announces In-Licensing of BL-9020, for Treatment of Type 1 Diabetes
    5. BioLineRx Announces Regulatory Submission for Phase 1/2 Trial for Novel Treatment of Celiac Disease
    6. BioLineRx Announces Receipt of a Notice of Allowance from USPTO for Patent on Use of BL-8020, an Oral, Interferon-Free Treatment for Hepatitis C
    7. BioLineRx To Present At 15th Annual Rodman & Renshaw Global Investment Conference In New York
    8. BioLineRx Announces Issuance of United States Patent Covering Use of BL-8040 for Obtaining Stem Cells
    9. BioLineRx to Present at 15th International Celiac Disease Symposium
    10. BioLineRx to Present at 2013 Stifel Nicolaus Healthcare Conference In Boston
    11. BioLineRx Appoints B. J. Bormann to Board of Directors
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/30/2014)...   Medical Equipment Solutions, Corp. are pleased ... of Defense (US Army) contract valued at over $2 ... diagnostic machine and technical support staffing. As an 8-A ... Business Administration (SBA), Medical Equipment is proud to support ... medical diagnostic equipment. The SBA 8-A certification is a ...
    (Date:7/30/2014)... INCLINE VILLAGE, Nev. , July 30, 2014 /PRNewswire/ ... today announced that company management will participate in the ... Boston , Massachusetts. The conference will occur on ... About PDL BioPharma, Inc. PDL BioPharma ... primarily of its Queen et al. antibody humanization patents ...
    (Date:7/29/2014)... CAMBRIDGE, Mass. and HERZLIYA PITUACH, ... Inc. (OTCQX and NASDAQ OMX First North Premier, ... announces today that it has initiated the screening of ... trial exploring the safety and efficacy of bertilimumab in ... open-label trial will enroll 10-15 patients who will receive ...
    Breaking Medicine Technology:Medical Equipment Solutions Corp. Awarded $2 Million contract To Service DoD 2PDL BioPharma to Participate in Jefferies 2014 Boston Healthcare Summit 2Immune Pharmaceuticals Commences Patient Screening For Bertilimumab Phase II Clinical Trial In Bullous Pemphigoid, A Rare Auto-Immune Disease Of The Skin 2Immune Pharmaceuticals Commences Patient Screening For Bertilimumab Phase II Clinical Trial In Bullous Pemphigoid, A Rare Auto-Immune Disease Of The Skin 3Immune Pharmaceuticals Commences Patient Screening For Bertilimumab Phase II Clinical Trial In Bullous Pemphigoid, A Rare Auto-Immune Disease Of The Skin 4Immune Pharmaceuticals Commences Patient Screening For Bertilimumab Phase II Clinical Trial In Bullous Pemphigoid, A Rare Auto-Immune Disease Of The Skin 5
    ... A Duke University pioneer in personalized medicine at today,s ... Conference said physicians must lead the way in changing ... care. , Dr. Ralph Snyderman, director of the Duke ... personalized medicine based on genetic and other individual patient ...
    ... 1 This fall, dog owners in New York City ... walk in the park. Veterinarians on the Mobile Dog Heart ... with a soundproof medical unit to perform free heart examinations ... disease. , (Photo: http://www.newscom.com/cgi-bin/prnh/20091001/CG85941 ) , In addition to ...
    Cached Medicine Technology:Personalized Medicine Expert: Don't 'Fix It,' 'Predict It' 2Mobile Dog Heart Health Tour Stopping in Central Park to Provide Free Heart Examinations 2Mobile Dog Heart Health Tour Stopping in Central Park to Provide Free Heart Examinations 3
    (Date:7/31/2014)... The study, The Truth Behind Variation in ... care payments for four clinical areas—congestive heart failure, acute ... and knees). Using the definition of episodes of ... program, the study examines these clinical areas within the ... , “Our study reaffirms that, in most instances, the ...
    (Date:7/30/2014)... Calling all runners in the Richmond, VA region. ... host a monthly Runner’s Injury Clinic at the ... the second Monday of each month through the end of ... 10 and December 8. , The clinics run from ... running shoes and attire, will receive a complimentary evaluation of ...
    (Date:7/30/2014)... Park Cities Pet Sitter President , ... month to reinforce best practices when communicating with fellow ... institute the meetings when she realized how much more ... over the past decade. Even with the addition ... quicker processing of customer requests and information, and ...
    (Date:7/30/2014)... (SCID) can be successfully treated with a transplant of ... Sloan Kettering,s Richard J. O,Reilly, MD, a world-renowned pioneer ... be published in the July 30 issue of the ... is a group of inherited disorders that cause the ... babies no longer have the ability to fight off ...
    (Date:7/30/2014)... Washington, DC and Malaysia (PRWEB) July 30, 2014 ... impact lives through education by LTT Global an award ... been pioneering learning on the go since 2004. , ... free and quality learning content. MMU has links ... providers, universities, organizations, NGOs’ and subject matter experts from ...
    Breaking Medicine News(10 mins):Health News:Recent Research Finds a New Driver of Cost Variation in Episode Payments 2Health News:Recent Research Finds a New Driver of Cost Variation in Episode Payments 3Health News:Tidewater Physical Therapy to Host Monthly Runner’s Injury Clinic at 3 Sports Glen Allen Location 2Health News:Tidewater Physical Therapy to Host Monthly Runner’s Injury Clinic at 3 Sports Glen Allen Location 3Health News:Dallas-Based Park Cities Pet Sitter Stresses the Importance of Mindful Communication in This Month’s Staff Meetings, In Addition to Teaching the Signs of Burnout 2Health News:Dallas-Based Park Cities Pet Sitter Stresses the Importance of Mindful Communication in This Month’s Staff Meetings, In Addition to Teaching the Signs of Burnout 3Health News:Dallas-Based Park Cities Pet Sitter Stresses the Importance of Mindful Communication in This Month’s Staff Meetings, In Addition to Teaching the Signs of Burnout 4Health News:Transplantation shown to be highly effective in treating immune deficiency in children 2Health News:MyMobileUniversity Inviting Individuals, Who Are Passionate about the Universal Right to Education, to Come on Board as Goodwill Ambassadors 2Health News:MyMobileUniversity Inviting Individuals, Who Are Passionate about the Universal Right to Education, to Come on Board as Goodwill Ambassadors 3
    ... of getting the heart disease in higher among teenagers ... de Simone and other researchers from the New York ... communities in Arizona, Oklahoma, and North and South Dakota, ... data from examinations of 460 participants aged 14-20 years ...
    ... In case you thought that you were a great exercise ... of urban air pollution, you might have to do a ... an environmentalist exhaust and smoke from buses, cars etc can ... this danger is expressed by Dr. Joseph T. Cooke, Associate ...
    ... by researchers from Cornell University has pointed out to the ... consequence of acid rain// and alteration in the soil nature ... establishment of factories in the U.S. ,The sugar ... eastern United States because of its high-priced lumber, syrup and ...
    ... the area of personalized genetics will soon enable people ... //This will be possible by scanning and deciphering the ... ,This is indeed a major achievement that can ... permitting the medical specialists to advice them based on ...
    ... after eating (traditionally called European siesta) has been confirmed by ... levels//. ,Brain cells responsible for mind and body ... switched off after eating, and thus we are in need ... ,A tiny protein called orexins was released from ...
    ... sponsored conference on aviation flu has called for ... involving all relevant institutions across the globe, including ... watchers and wildlife conservation societies to check spread ... attending the conference convened by the UN Food ...
    Cached Medicine News:Health News:Growth Of Maple Trees Affected By Acid Rain 2Health News:Growth Of Maple Trees Affected By Acid Rain 3
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    Medicine Products: